In a rapidly evolving technical and IP landscape, companies seeking protection for emerging innovations must continually monitor new developments that can pose critical threats to their portfolios and patent portfolio. Keeping a close eye on changes to pending applications from competitors, legal action on related similar patents, emerging prior art, and new publications is a critical practice for those seeking…
With today’s accelerated pace of innovation, it is essential for organizations to leverage comprehensive IP insights to inform R&D, fuel strategic decisions, and protect their investments. At the same time, executing IP search projects in rapidly evolving domains is incredibly complex, requiring ongoing collaboration and alignment between R&D teams, attorneys, IP managers, and search professionals. Poor communication, incomplete or inaccurate…
Nearly 30% of biologics patent rejections result from a lack of adequate description. Rejections of this sort may rise in light of the Supreme Court’s decision in Amgen v. Sanofi. Increasingly, building strong patent applications in this complex and litigious biologics space will require more robust specifications, with solid and well-supported claims, which means applications backed by strong IP searches…
The increasingly crowded and complex biologics space is evolving faster than the ability of companies to manage sequence information to secure and protect their valuable IP assets. Missing critical sequence IP information during biologics R&D can delay progress and result in weaker patent claims, missed opportunity, and greater legal risks. Join us on Thursday, June 22, 2023, at 12:00 PM…
The process for developing new biotech therapies can easily put R&D and intellectual property leaders in uncharted territory. From lead selection to freedom to operate, it is not unusual to request a dozen patent and scientific literature searches to help guide researchers as they attempt to maximize value and opportunity. Collaboration, communication, and thorough research facilitate the innovation to commercialization…
The transformation of intellectual property (IP) management within commercial companies is driving the adoption of new practices and technologies to more closely align IP objectives with growth strategies, unlock greater portfolio value, and support strategic decision-making across enterprises. Nowhere is that more critical than at the nexus of IP and Research and Development (R&D), where organizations are applying IP insights…
Webinar Sponsored By: Companies are using product licensing, patent transactions, mergers and acquisitions to build patent portfolios for various reasons and as part of new growth strategies. But searching in the life sciences and biochemical technology areas is extraordinarily complex and projects require multiple people to be aligned on goals and strategies. Searching for advances in chemistry and related sciences…
Webinar Sponsored By: Companies are using product licensing, patent transactions, mergers and acquisitions to build patent portfolios for various reasons and as part of new growth strategies. But searching in the life sciences and biochemical technology areas is extraordinarily complex and projects require multiple people to be aligned on goals and strategies. Searching for advances in chemistry and related sciences…